{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:38:25Z","timestamp":1788273505956,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although serum NT-proBNP is a useful marker of patent ductus arteriosus (PDA) severity in the early postnatal period, its ability to predict the future need for PDA surgery remains unclear. This study aimed to compare the predictive abilities of early NT-proBNP and the PLASE score using an established echocardiographic model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Infants born at 23\u201329 weeks of gestation between 2019 and 2024 and admitted to a tertiary neonatal intensive care unit were included. Serum NT-proBNP levels and echocardiographic indices at 3 days of age were retrospectively collected. Three predictive models were evaluated: Model 1, the PLASE score (reference); Model 2, log\n                      <jats:sub>10<\/jats:sub>\n                      (NT-proBNP); and Model 3, log\n                      <jats:sub>10<\/jats:sub>\n                      (NT-proBNP) plus gestational age (weeks).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 126 infants included, 23 (18%) underwent PDA surgery. The ROC-AUCs (95% CI) were 0.829 (0.748\u20130.910) for Model 1, 0.669 (0.539\u20130.798) for Model 2, and 0.826 (0.741\u20130.911) for Model 3. Model 1 yielded higher ROC-AUC than Model 2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02), whereas no significant difference was observed between Model 1 and Model 3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.94).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early postnatal NT-proBNP combined with gestational age showed high predictive ability comparable to the PLASE score. NT-proBNP could be used to estimate the likelihood of future PDA surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>N-terminal pro-B-type natriuretic peptide (NT-proBNP) measured at 3 days of age, when combined with gestational age, demonstrated high predictive ability for patent ductus arteriosus (PDA) surgery (Area under the receiver operating characteristic curve: 0.826).<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Early postnatal NT-proBNP yielded results equivalent to those of the PLASE score, an echocardiographic prediction model.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>This study suggests that early NT-proBNP assessment may complement echocardiographic evaluation in the management of PDA.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-026-05339-z","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:27:46Z","timestamp":1785868066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the predictive ability for PDA surgery between early serum NT-proBNP level and echocardiographic PLASE score"],"prefix":"10.1038","author":[{"given":"Yusuke","family":"Morita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongsun","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Shimokaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Tomotaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Isayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"5339_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1651-2227.2004.tb02984.x","volume":"93","author":"A Nir","year":"2004","unstructured":"Nir, A. et al. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 93, 603\u2013607 (2004).","journal-title":"Acta Paediatr."},{"key":"5339_CR2","first-page":"CD013129","volume":"12","author":"G Gokulakrishnan","year":"2022","unstructured":"Gokulakrishnan, G. et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates. Cochrane Database Syst. Rev. 12, CD013129 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"5339_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/cc2890","volume":"8","author":"R Witthaut","year":"2004","unstructured":"Witthaut, R. Science review: natriuretic peptides in critical illness. Crit. Care 8, 342\u2013349 (2004).","journal-title":"Crit. Care"},{"key":"5339_CR4","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.clinbiochem.2010.08.002","volume":"43","author":"M Sahin","year":"2010","unstructured":"Sahin, M., Portakal, O., Karagoz, T., Hascelik, G. & Ozkutlu, S. Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin. Biochem. 43, 1278\u20131281 (2010).","journal-title":"Clin. Biochem."},{"key":"5339_CR5","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1542\/peds.2008-2418","volume":"123","author":"S Noori","year":"2009","unstructured":"Noori, S. et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123, e138\u2013e144 (2009).","journal-title":"Pediatrics"},{"key":"5339_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jpeds.2005.06.039","volume":"147","author":"W Oh","year":"2005","unstructured":"Oh, W. et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J. Pediatr. 147, 786\u2013790 (2005).","journal-title":"J. Pediatr."},{"key":"5339_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1203\/PDR.0b013e3181c1b176","volume":"67","author":"P Ballabh","year":"2010","unstructured":"Ballabh, P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr. Res. 67, 1\u20138 (2010).","journal-title":"Pediatr. Res."},{"key":"5339_CR8","first-page":"184","volume":"40","author":"S Dollberg","year":"2005","unstructured":"Dollberg, S., Lusky, A. & Reichman, B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J. Pediatr. Gastroenterol. Nutr. 40, 184\u2013188 (2005).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5339_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1067\/mpd.2000.106569","volume":"137","author":"M Kluckow","year":"2000","unstructured":"Kluckow, M. & Evans, N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J. Pediatr. 137, 68\u201372 (2000).","journal-title":"J. Pediatr."},{"key":"5339_CR10","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1542\/peds.2014-1995","volume":"135","author":"M Kulkarni","year":"2015","unstructured":"Kulkarni, M. et al. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics 135, e510\u2013e525 (2015).","journal-title":"Pediatrics"},{"key":"5339_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/CH-190803","volume":"75","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: How and when? Clin. Hemorheol. Microcirc. 75, 335\u2013347 (2020).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"5339_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00431-018-3089-y","volume":"177","author":"SL Harris","year":"2018","unstructured":"Harris, S. L. et al. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus. Eur. J. Pediatr. 177, 521\u2013532 (2018).","journal-title":"Eur. J. Pediatr."},{"key":"5339_CR13","doi-asserted-by":"publisher","first-page":"F257","DOI":"10.1136\/adc.2007.120691","volume":"93","author":"I Farombi-Oghuvbu","year":"2008","unstructured":"Farombi-Oghuvbu, I., Matthews, T., Mayne, P. D., Guerin, H. & Corcoran, J. D. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch. Dis. Child Fetal Neonatal Ed. 93, F257\u2013F260 (2008).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5339_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/jcm11030667","volume":"11","author":"A Gudmundsdottir","year":"2022","unstructured":"Gudmundsdottir, A. et al. Early N-terminal pro B-type natriuretic peptide (NTproBNP) plasma values and associations with patent ductus arteriosus closure and treatment-an echocardiography study of extremely preterm infants. J. Clin. Med. 11, 667 (2022).","journal-title":"J. Clin. Med"},{"key":"5339_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41390-025-03803-w","volume":"98","author":"S Masutani","year":"2025","unstructured":"Masutani, S. et al. Generation of PLASE score for patent ductus arteriosus using the PLASE study database. Pediatr. Res. 98, 152\u2013160 (2025).","journal-title":"Pediatr. Res"},{"key":"5339_CR16","doi-asserted-by":"publisher","unstructured":"Morita, Y., et al. External validation of the PLASE score prediction model for PDA surgery. Pediatr. Cardiol. 1\u20137, https:\/\/doi.org\/10.1007\/s00246-025-04096-w (2025). Online ahead of print.","DOI":"10.1007\/s00246-025-04096-w"},{"key":"5339_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jjcc.2014.11.002","volume":"66","author":"C Kurishima","year":"2015","unstructured":"Kurishima, C. et al. Cystatin C and body surface area are major determinants of the ratio of N-terminal pro-brain natriuretic peptide to brain natriuretic peptide levels in children. J. Cardiol. 66, 175\u2013180 (2015).","journal-title":"J. Cardiol."},{"key":"5339_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg, E. W. et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128\u2013138 (2010).","journal-title":"Epidemiology"},{"key":"5339_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1651-2227.2009.01315.x","volume":"98","author":"S Ramakrishnan","year":"2009","unstructured":"Ramakrishnan, S. et al. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr. 98, 1254\u20131259 (2009).","journal-title":"Acta Paediatr."},{"key":"5339_CR20","doi-asserted-by":"publisher","first-page":"e20164258","DOI":"10.1542\/peds.2016-4258","volume":"140","author":"J Semberova","year":"2017","unstructured":"Semberova, J. et al. Spontaneous Closure of Patent Ductus Arteriosus in Infants <\/=1500 g. Pediatrics 140, e20164258 (2017).","journal-title":"Pediatrics"},{"key":"5339_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1651-2227.2008.00871.x","volume":"97","author":"C Dani","year":"2008","unstructured":"Dani, C. et al. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr. 97, 1176\u20131180 (2008).","journal-title":"Acta Paediatr."},{"key":"5339_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000113058","volume":"94","author":"J Madan","year":"2008","unstructured":"Madan, J., Fiascone, J., Balasubramanian, V., Griffith, J. & Hagadorn, J. I. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin. Neonatology 94, 45\u201351 (2008).","journal-title":"Neonatology"},{"key":"5339_CR23","doi-asserted-by":"publisher","first-page":"F133","DOI":"10.1136\/adc.2010.185967","volume":"96","author":"AF El-Khuffash","year":"2011","unstructured":"El-Khuffash, A. F., Slevin, M., McNamara, P. J. & Molloy, E. J. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 96, F133\u2013F137 (2011).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5339_CR24","doi-asserted-by":"publisher","first-page":"F320","DOI":"10.1136\/adc.2006.106039","volume":"92","author":"A El-Khuffash","year":"2007","unstructured":"El-Khuffash, A. & Molloy, E. J. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch. Dis. Child Fetal Neonatal Ed. 92, F320\u2013F324 (2007).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05339-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:20:45Z","timestamp":1788236445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05339-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":24,"alternative-id":["5339"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05339-z","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The parents or guardians of infants admitted to the NICU were not required to give informed consent for the infants\u2019 participation in the study because the analysis used anonymized clinical data that were obtained after the guardians of each patient agreed to treatment by providing their written consent. We also adopted an opt-out system and posted a summary of the study on the hospital\u2019s website.","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}